Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The prognostic role of thyroid transcription factor-1 in lung adenocarcinoma.

Journal of cancer research and therapeutics - 1 Jan 2000

Oktay Esin, Oflazoglu Utku, Varol Yelda, Tanriverdi Ozgur, Mermur Necla, Arda Hayri Ustun, Demir Lutfiye, Keskin Ozge, Ahmadli Tural, Somali Isil, Oztop Ilhan, Meydan Nezih

Abstract excerpt

AIMS: In this study, we investigated the expression of thyroid transcription factor-1 (TTF-1) in lung adenocarcinoma patients' samples and analyzed the association of TTF-1 with clinicopathological parameters, prognosis, and treatment options in patients with lung adenocarcinoma. SUBJECTS AND METHODS: This retrospective study enrolled 200 patients who were histologically confirmed lung adenocarcinoma with Stage...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma of Lung
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Lung Neoplasms

Share to Neoplasm Staging

Share to Prognosis

Share to Survival Rate

Share to Thyroid Nuclear Factor 1

Source

Identifiers

PMID: 32930112
DOI: 10.4103/jcrt.JCRT_1404_16

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The prognostic role of thyroid transcription factor-1 in lung adenocarcinoma.PMID 32930112Read ↗

Prognostic impact of TTF-1 expression in patients with stage IV lung adenocarcinomas.Semantic proximity Read ↗

Negative Thyroid Transcription Factor 1 Expression Defines an Unfavorable Subgroup of Lung AdenocarcinomasSemantic proximity Read ↗

Thyroid transcription factor 1 (TTF-1) negativity as a predictor of unfavorable response to EGFR-TKI therapy in advanced lung adenocarcinoma patients with EGFR mutations.Semantic proximity Read ↗

Thyroid Transcription Factor 1 Is an Independent Prognostic Factor for Patients With Stage I Lung AdenocarcinomaSemantic proximity Read ↗

Molecular genetic alterations in thyroid transcription factor 1-negative lung adenocarcinoma in cytology specimens: A subset with aggressive behavior and a poor prognosis.Semantic proximity Read ↗

Association of thyroid transcription factor‐1 with the efficacy of immune‐checkpoint inhibitors in patients with advanced lung adenocarcinomaSemantic proximity Read ↗

Clinical significance of TTF‐1 protein expression and <i>TTF‐1</i> gene amplification in lung adenocarcinomaSemantic proximity Read ↗

The relationship between TTF-1 expression and EGFR mutations in lung adenocarcinomas.Semantic proximity Read ↗

TTF-1 Expression in Lung Adenocarcinoma: Clinicopathologic, Genomic, and Immunophenotypic Correlates and Outcomes to Immunotherapy-Based Treatments and KRASG12C Inhibitors.Semantic proximity Read ↗

Pemetrexed-Based Chemotherapy Is Inferior to Pemetrexed-Free Regimens in Thyroid Transcription Factor 1 (TTF-1)-Negative, EGFR/ALK-Negative Lung Adenocarcinoma: A Propensity Score Matched Pairs Analysis.Semantic proximity Read ↗

Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry studySemantic proximity Read ↗

Retrospective Data Analysis of Patients With Metastatic Lung Adenocarcinoma With or Without KRAS-Mutation or TTF1-Expression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.